NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹66 Cr | ₹71 Cr | ₹85 Cr | ₹96 Cr | ₹100 Cr |
What is the latest Long Term Provisions ratio of NATCO PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹66 Cr |
| Mar2024 | ₹71 Cr |
| Mar2023 | ₹85 Cr |
| Mar2022 | ₹96 Cr |
| Mar2021 | ₹100 Cr |
How is Long Term Provisions of NATCO PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹66 Cr | -7.48 | |
| Mar2024 | ₹71 Cr | -16.88 | |
| Mar2023 | ₹85 Cr | -10.87 | |
| Mar2022 | ₹96 Cr | -3.92 | |
| Mar2021 | ₹100 Cr | - | |
Compare Long Term Provisions of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹21,563.6 Cr | 2.6% | 11.8% | 44.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,032.0 Cr | 0.9% | 12.8% | 4.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹183,759.0 Cr | 3.2% | 14% | 13.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,224.0 Cr | 0.7% | 5.5% | 36.9% | Stock Analytics | |
| CIPLA | ₹116,214.0 Cr | 6.8% | 18.8% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,739.0 Cr | 0.7% | 5.5% | 9.4% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 2.6% |
11.8% |
44.9% |
| SENSEX | -3.1% |
-2.8% |
-6.1% |
You may also like the below Video Courses